Souhaitez-vous accéder aux communiqués récents ?

Numab to receive first milestone payment Boehringer Ingelheim has advanced its novel tumor antigen targeting T cell engager resulting from a collaboration with Numab into preclinical...

Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Microfluidics Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The global microfluidics market is poised...

Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Flow Cytometry Services Market Industry Trends and Global Forecasts to 2035: Distribution by Service, Type of Analysis based Flow Cytometric Services,...

Dublin, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The "Biobanking Market - A Global and Regional Analysis: Focus on Product and Service, Storage Type, Sample Type, Ownership, Biobank Type, Application,...

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Europe Flow Cytometry Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe flow cytometry...

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Flow Cytometry Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Asia-Pacific...

Dublin, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The "Valeo 2022 - 2025 Healthcare Law Firm Hourly Rate Report" report has been added to ResearchAndMarkets.com's offering. Using state-of-the-art...

Dublin, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The "Biotech, Pharmaceuticals & Genetics Industry Almanac 2026: Market Research, Statistics, Trends and Leading Companies" book from Plunkett Research...

HORGEN, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Numab Therapeutics AG (“Numab”), a biotechnology company advancing a proprietary pipeline of multi-specific antibodies in immunology and...

DALLAS, Sept. 08, 2025 (GLOBE NEWSWIRE) -- BioNTX proudly announces that John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), has been named the 2025 recipient of the...